Francesca Harris, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: Ctf 53/msc Cent, Psc 851 Box 509, Fpo, AE 09834 Phone: 858-964-6472 |
Chad Michael Thoemke, PA Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: Uss Harry S Truman Cvn 75, Fpo, AE 09524 Phone: 757-443-7733 |
Ms. Andrea Marie Tidd, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 66 Medical Squadron, 1900 Vandenburg Rd, Hanscom Afb, AE 01731 Phone: 781-225-6340 |
Lezlie Dawn Burke, MA Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: Building 51 Truppenuebungsplatz, Hohenfels, AE 92366 Phone: 491-702-1682 |
News Archive
Amgen Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has announced a positive opinion for the marketing authorization of Prolia((TM)) (denosumab) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures.
Skyrocketing price tags for new drugs to treat rare diseases have stoked outrage nationwide. But hundreds of old, commonly used drugs cost the Medicaid program billions of extra dollars in 2016 vs. 2015, a Kaiser Health News data analysis shows.
It has been more than 50 years since the U.S. Food and Drug Administration (FDA) last approved a new medicine specifically for lupus – when Dwight D. Eisenhower was president. Existing treatments have been "borrowed" from other disorders and the risk/benefit ratio of these treatments is far from optimal. However, hope is on the horizon.
Researchers from Thomas Jefferson University have identified a protein that appears to play a significant role in the growth and migration of prostate cancer cells, especially androgen-independent prostate cancer cells.
› Verified 9 days ago